US President Donald Trump's second term is expected to bring widespread changes. In the biotech industry ... In a post on X after his October nomination, Kennedy issued a warning: “FDA ...

Amid the growing trade tensions between the US and China, Chinese firms are also divesting in North America, according to the report, with $9.6 billion being divested in the first half of the year.

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass ...

as biotech emerges as a new front in the escalating US-China tech war. Akeso's new immunotherapy drug targeting non-small cell lung cancer, called ivonescimab, allowed half of its patients to go ...

Other Chinese drug companies like Hutchmed and Legend Biotech have set up operations in New Jersey and are hiring aggressively, with plans to bring their drugs to the US market as well.

The biotech's oral formulation of VK2735 passed phase 1 studies with flying colors, too. Meanwhile, it is developing VK0214 as a potential medicine for X-linked adrenoleukodystrophy, a rare ...

The Chinese biotech industry has grown rapidly to become a major hub of research. However, as US-China trade relations continue to deteriorate, Ben Hargreaves asks whether this could stunt ...

The country wants to launch financing for the efforts as soon as possible, according to a March 20 letter penned by Netherlands’ Education Minister Eppo Bruins and obtained by Fierce Biotech.

as biotech emerges as a new front in the escalating US-China tech war. Akeso’s new immunotherapy drug targeting non-small cell lung cancer, called ivonescimab, allowed half of its patients to go ...